Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents

Journal of the American Academy of Child and Adolescent Psychiatry
H L LeonardA J Allen

Abstract

To review the pharmacology of a new class of medications, the potent selective serotonin reuptake inhibitors (SSRIs), what is known about their metabolism in children and adolescents, and the practical clinical implications of such. Articles were retrieved through index Medicus searches for articles published during the past 10 years on the SSRIs and on pediatric pharmacology. More than 300 articles were reviewed. Pharmacological data, derived from relevant adult literature, were summarized and extrapolated to children and from the limited pediatric literature. The SSRIs represent a new class of antidepressants with distinct advantages in their side effect profile and their broad therapeutic index over that seen with the tricyclic antidepressants. Their advantage of few anticholinergic side effects and limited cardiovascular toxicities are particularly relevant for the pediatric population. The SSRIs are metabolized via the hepatic cytochrome isoenzyme P450 system, and potential drug-drug interactions are reviewed. The SSRIs appear to offer advantages over the tricyclic antidepressants. Unfortunately, pharmacokinetic data are lacking, and systematic studies of safety and efficacy in the pediatric age group are limited. Prelimin...Continue Reading

References

Sep 1, 1992·British Journal of Clinical Pharmacology·E Skjelbo, K Brøsen
Nov 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·M A RiddleD J Cohen
Oct 1, 1992·International Clinical Psychopharmacology·S J Warrington
Jan 1, 1992·Clinical Neuropharmacology·M Bourin, A Couetoux du Tertre
Jan 1, 1992·Clinical Neuropharmacology·S A Montgomery
Oct 1, 1992·The American Journal of Psychiatry·N S Achamallah
Mar 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·S VenkataramanC A King
May 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·A M Walters
Nov 1, 1991·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A D Sperber
Oct 1, 1991·BMJ : British Medical Journal·C M BeasleyD N Masica
Oct 1, 1991·The American Journal of Psychiatry·N S Achamallah, D H Decker
Sep 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·L Jerome
Sep 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·C B HershC R Pfeffer
Sep 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·A B Jafri, W M Greenberg
Feb 1, 1990·Journal of Clinical Psychopharmacology·D A Ciraulo, R I Shader
Jan 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·M G BartelsS J Stamm
Mar 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·R A KingL Scahill
Jun 1, 1991·The American Journal of Psychiatry·H Sternbach
Oct 1, 1990·Journal of Clinical Psychopharmacology·R Hoehn-SaricD R McLeod
Nov 1, 1990·Journal of the American Academy of Child and Adolescent Psychiatry·J S MarchH Johnston
Feb 1, 1990·The American Journal of Psychiatry·M H TeicherJ O Cole
Jul 1, 1990·The American Journal of Psychiatry·M CunninghamR B Lydiard
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·G C Dunbar
Jul 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·M A RiddleJ L Woolston
Apr 1, 1984·Journal of Clinical Psychopharmacology·M Ostow
Jan 1, 1995·The American Journal of Psychiatry·D M Coulter, P I Pillans
Jan 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·D A GellerT E Wilens
Dec 1, 1994·Journal of Clinical Psychopharmacology·R I ShaderL L von Moltke
Mar 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·C L BudmanR D Bruun
Feb 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·D W Gillette, L P Tannery
Jun 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·S FennigA Weitzman
Sep 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·J P Horrigan, L J Barnhill
Sep 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·B BirmaherM Brodsky
Jan 1, 1994·European Journal of Clinical Pharmacology·J C Fleishaker, L K Hulst
May 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·R J EdlemanK H Ehlers
Apr 10, 1993·Lancet·T WalleyD Maxwell
Feb 1, 1994·Journal of Clinical Psychopharmacology·L L von MoltkeR I Shader
Dec 1, 1993·Seizure : the Journal of the British Epilepsy Association·V P Prasher
Mar 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·A ApterM A Riddle
Jun 1, 1994·The American Journal of Psychiatry·M Ghaziuddin
Apr 1, 1994·Journal of Clinical Psychopharmacology·S H PreskornS Harris
Feb 1, 1994·The American Journal of Psychiatry·L Shihabuddin, D Rapport
Feb 1, 1994·The American Journal of Psychiatry·L C BarrL H Price
Jul 1, 1993·The American Journal of Psychiatry·R B LydiardT Cunningham

❮ Previous
Next ❯

Citations

Aug 10, 2006·Psychopharmacology·Khrista BoylanBoris Birmaher
Jan 5, 2001·European Child & Adolescent Psychiatry·C F Ziervogel
Oct 16, 2003·Pediatric Clinics of North America·Christopher K Varley, Cindy J Smith
Jan 13, 1999·Pediatric Clinics of North America·M J LabellarteM A Riddle
Jan 13, 1999·Pediatric Clinics of North America·B BirmaherJ Renaud
Nov 13, 2002·Journal of Child and Adolescent Psychopharmacology·John WalkupUNKNOWN Research Units on Pediatric Psychopharmacology Anxiety Study Group
Jun 14, 2003·Journal of Child and Adolescent Psychopharmacology·Harpreet S DuggalCraig C Coleman
Jul 26, 2003·Journal of Child and Adolescent Psychopharmacology·Martin FranklinJohn S March
May 15, 2004·Journal of Child and Adolescent Psychopharmacology·David CohenMartine F Flament
May 25, 2005·Journal of Child and Adolescent Psychopharmacology·Elham Shirazi, Javad Alaghband-Rad
Sep 3, 2010·Journal of Child and Adolescent Psychopharmacology·Elana HarrisShannon N Saldaña
Apr 13, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·S F Boyle
May 7, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·K Manassis, M Owens
May 7, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·T E WilensT J Spencer
May 3, 2001·Journal of Developmental and Behavioral Pediatrics : JDBP·M T SteinL J Schneiderman
Sep 23, 2000·Journal of Clinical Psychopharmacology·R S DilerA Avci
Feb 24, 2001·International Clinical Psychopharmacology·S SeedatD J Stein
Aug 19, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Michael J LabellarteMark A Riddle
Oct 10, 2003·CNS Drugs·Maria NobileMassimo Molteni
Oct 24, 1998·Journal of the American Academy of Child and Adolescent Psychiatry
May 20, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·A J ZametkinR Silver
Apr 11, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Graham J EmslieYunfeng Li
Dec 3, 2005·Child and Adolescent Psychiatric Clinics of North America·Joseph M Rey, Andrés Martin
Jun 27, 2006·Child and Adolescent Psychiatric Clinics of North America·Frederick J StoddardAnnah N Abrams
Apr 18, 2007·Pediatric Blood & Cancer·Leslie S Kersun, Josephine Elia
Mar 13, 2014·Journal of Paediatrics and Child Health·Michael Gordon, Glenn A Melvin
Aug 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Alexander M Scharko
Feb 24, 2006·The Journal of Pediatrics·Paul G HammernessDaniel A Geller
Mar 1, 2002·Expert Review of Neurotherapeutics·E Jane Garland
Jul 1, 2002·Expert Review of Neurotherapeutics·Gabriele MasiMaria Mucci
Jan 25, 2008·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Teresa L KramerJames M Robbins
Mar 12, 2002·The Journal of School Nursing : the Official Publication of the National Association of School Nurses·M R Gardner
Feb 13, 2002·Journal of Child and Adolescent Psychopharmacology·S J Brooks, S Kutcher
Oct 31, 2002·Human Psychopharmacology·Floyd R SalleeLauren Sine
Jan 26, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Julie A Dopheide
Mar 1, 2004·Irish Journal of Psychological Medicine·Louise Sharkey, Ann O'Donovan
Dec 14, 2002·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders
Jun 24, 2017·Journal of Pediatric Gastroenterology and Nutrition·Claire A M Zar-KesslerBraden M Kuo
Sep 8, 1998·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·K Minde
Jan 5, 2001·European Child & Adolescent Psychiatry·P H Thomsen
Sep 1, 2001·Paediatrics & Child Health·W P Fleisher, L Y Katz
Feb 3, 2005·Journal of Psychosocial Nursing and Mental Health Services·Vanya Hamrin, Maryellen C Pachler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Child and Adolescent Psychopharmacology
J T Walkup, M Labellarte
Journal of Child Psychology and Psychiatry, and Allied Disciplines
Amy H CheungTaryn L Mayes
Journal of the American Academy of Child and Adolescent Psychiatry
Boris BirmaherM Brodsky
© 2021 Meta ULC. All rights reserved